- Brand: Janumet XRGeneric: Sitagliptin and Metformin HCl
- Brand: Kombiglyze XRGeneric: Saxagliptin and Metformin HCl Extended-Release
- Brand: InvokametGeneric: Canagliflozin and Metformin Hydrochloride Tablets
- Brand: JanumetGeneric: Sitagliptin Metformin HCL
- Brand: Invokamet XRGeneric: canagliflozin and metformin hydrochloride
- Brand: JentaduetoGeneric: Linagliptin and Metformin Hydrochloride
- Brand: Jentadueto XRGeneric: Linagliptin and Metformin Hydrochloride Extended-release Tablets
- Brand: KazanoGeneric: Alogliptin and Metformin HCl Tablets
- Brand: Xigduo XRGeneric: Dapagliflozin and Metformin HCl Extended-release Tablets
- Brand: AvandarylGeneric: Rosiglitazone Maleate and Glimepiride
- Brand: AvandametGeneric: Rosiglitazone Maleate and Metformin HCl
- Brand: MetaglipGeneric: Glipizide and Metformin
- Brand: SynjardyGeneric: Empagliflozin and Metformin Hydrochloride Tablets
- Brand: Synjardy XR Extended-release TabletsGeneric: Empagliflozin and Metformin Hydrochloride Extended-release
- Brand: InvokanaGeneric: Canagliflozin Tablets
- Brand: FarxigaGeneric: Dapagliflozin Film-coated Tablets
- Brand: VictozaGeneric: Liraglutide [rDNA] Injection
- Brand: Actoplus MET, Actoplus MET XRGeneric: Pioglitazone Hcl and Metformin Hcl
- Brand: SeglurometGeneric: Ertugliflozin and Metformin Hydrochloride Tablets
- Brand: OnglyzaGeneric: Saxagliptin Tablets
- Brand: JanuviaGeneric: Sitagliptin Phosphate
- Brand: RiometGeneric: Metformin Hcl
- Brand: JuvisyncGeneric: Sitagliptin and Simvastatin
- Brand: TradjentaGeneric: Linagliptin
- Brand: FortametGeneric: Metformin Hcl
- Brand: NesinaGeneric: Alogliptin Tablets
- Brand: Glucophage, Glucophage XRGeneric: Metformin Hcl
- Brand: GlumetzaGeneric: Metformin Hcl
- Brand: JardianceGeneric: Empagliflozin Tablets
- Brand: GlucovanceGeneric: Glyburide and Metformin
- Brand: PrandimetGeneric: Repaglinide and Metformin HCl Tablets
- Brand: AvandiaGeneric: Rosiglitazone Maleate
- Brand: BydureonGeneric: Exenatide
- Brand: TanzeumGeneric: Albiglutide Pen for Injection, for Subcutaneous Use
- Brand: Starlix TabletGeneric: Nateglinide
- Brand: TrulicityGeneric: Dulaglutide Injection, for Subcutaneous Use
- Brand: Starlix TabletGeneric: Nateglinide
- Brand: AdlyxinGeneric: Lixisenatide Injection
- Brand: OseniGeneric: Alogliptin and Pioglitazone Tablets
- Brand: Xultophy InjectionGeneric: Insulin Degludec and Liraglutide
- Brand: ActosGeneric: Pioglitazone Hydrochloride
- Brand: FiaspGeneric: Insulin Aspart Injection for Subcutaneous or Intravenous Use
- Brand: OzempicGeneric: Semaglutide Injection
- Brand: WelcholGeneric: Colesevelam Hcl
- Brand: SteglatroGeneric: Ertugliflozin Tablets for Oral Use
- Brand: PrecoseGeneric: Acarbose
- Brand: LevemirGeneric: Insulin Detemir
- Brand: SteglujanGeneric: Ertugliflozin and Sitagliptin Tablets
- Brand: ExuberaGeneric: Insulin Human [rDNA origin]
- Brand: ByettaGeneric: Exenatide Injection
- Brand: PrandinGeneric: Repaglinide
- Brand: Amaryl TabletsGeneric: Glimepiride
- Brand: QternGeneric: Dapagliflozin and Saxagliptin Tablets, for Oral Use
- Brand: Bydureon BciseGeneric: Exenatide Extended-Release Injectable Suspension
- Brand: NovoLog Mix 70/30Generic: Insulin Aspart Protamine and Insulin Aspart (rDNA origin)
- Brand: Soliqua InjectionGeneric: Insulin Glargine and Lixisenatide
- Brand: Qudexy XRGeneric: Topiramate Extended-Release Capsules
- Brand: KeflexGeneric: Cephalexin
- Brand: TresibaGeneric: Insulin Degludec Injection
- Brand: GlyxambiGeneric: Empagliflozin and Linagliptin Tablets
- Brand: DuetactGeneric: Pioglitazone Hydrochloride and Glimepiride Tablets
- Brand: Trokendi XRGeneric: Topiramate Extended-release Capsules
- Brand: RanexaGeneric: Ranolazine
- Brand: TopamaxGeneric: Topiramate
- Brand: QsymiaGeneric: Phentermine and Topiramate
- Brand: MicronaseGeneric: Glyburide
- Brand: JulucaGeneric: Dolutegravir and Rilpivirine Tablets, for Oral Use
- Brand: Glynase PresTabGeneric: Micronized Glyburide Tablets
- Brand: TivicayGeneric: Doutegravir 50mg Tablets
- Brand: TriumeqGeneric: Abacavir, Dolutegravir, and Lamivudine Film-coated Tablets
- Brand: StendraGeneric: Avanafil
- Brand: CaprelsaGeneric: Vandetanib
- Brand: Corlanor Generic: Ivabradine Tablets
- Brand: CuvposaGeneric: Glycopyrrolate Oral Solution
- Brand: VerzenioGeneric: Abemaciclib Tablets
- Brand: Sanctura XRGeneric: Trospium Chloride Extended Release Capsule
- Brand: Adalat CCGeneric: Nifedipine
- Brand: Afeditab CRGeneric: Nifedipine Extended-Release Tablets
- Brand: SancturaGeneric: Trospium Chloride Tablets
- Brand: ChantixGeneric: Varenicline
- Brand: CyclosetGeneric: Bromocriptine Mesylate Tablets
- Brand: BiktarvyGeneric: Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets
- Brand: TechnivieGeneric: Ombitasvir, Paritaprevir and Ritonavir Tablets
- Brand: PrevymisGeneric: Letermovir Tablets
- Brand: Viekira PakGeneric: Ombitasvir, Paritaprevir, and Ritonavir tablets; Dasabuvir Tablets
- Brand: Viekira XRGeneric: Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir Extended-Release Tablets
- Brand: LipofenGeneric: Fenofibrate
Slideshows, Images, and Quizzes
- Picture of Polycystic Ovary SyndromeSource: RxList
View an Illustration of Picture of Polycystic Ovary Syndrome and learn more about Medical Anatomy.
Diseases, Conditions, and Procedures
- Types of Diabetes Type 2 MedicationsSource: MedicineNet
Consumer information about the types of type 2 diabetes medications. Read about the side effects of Precose, Diabinese, Amaryl, Glucophage, Actos, Avandia, Starlix, Prandin, and more. Drug interactions, dosing, storage, and breastfeeding and pregnancy safety information is provided.
- Diabetes Treatment: Medication, Diet, and InsulinSource: MedicineNet
Treatment of type 1 and type 2 diabetes and prediabetes include insulin, a diabetic diet, exercise, and medication. Guidelines for diabetes treatment varies by person. Learn about specific medications including side effects, and diet plan programs for diabetes, and other diabetes treatment options.
- Type 2 DiabetesSource: MedicineNet
Type 2 diabetes is a condition in which the cells cannot use blood sugar efficiently to meet the body’s needs. Symptoms include excessive thirst, frequent urination and weight loss, but many people don't know they have it without a blood test. Treatment options include medications, a type 2 diabetes diet, and other lifestyle changes.
- PrediabetesSource: MedicineNet
Prediabetes is a condition in which a person's blood sugar is higher than it should be, but it's not high enough to be full blown diabetes. Symptoms, signs, foods to eat, foods to avoid, healthy diet, exercise, and an prediabetes or HbA1c chart are provided.
- Insulin ResistanceSource: MedicineNet
Insulin resistance is a condition that is a precursor to developing type 2 diabetes. Causes of insulin resistance include metabolic syndrome, pregnancy, stress, obesity, and inactivity. Read about risk factors, diet information, lists of foods, and prevention.
- How to Prevent Diabetes NaturallySource: MedicineNet
Type 2 diabetes can be prevented naturally with a healthy lifestyle, for example, a Mediterranean diet, getting more exercise, quitting smoking, reducing stress, and in some cases, a combination of lifestyle changes and medication.
- Pregnancy and Drugs (Prescription and OTC)Source: Government
Are over-the-counter drugs, prescription drugs, or vitamin supplements safe while you are pregnant? Find out what medications may put you or your baby at risk.
- Fatty Liver (NASH)Source: MedicineNet
Nonalcoholic fatty liver disease, or NASH, is a disease due to an abnormal accumulation of fat within the liver. Eventually, NASH scars the liver, and it ultimately leads to cirrhosis or liver cancer. Usually, NASH causes no symptoms, but later in the progression of the disease, it may cause jaundice, blood clots, and coma. Treatment for fatty liver includes diet, exercise, medication, and surgery.
- What Are Polycystic Ovarian Syndrome (PCOS) Symptoms?Source: MedicineNet
Polycystic Ovarian Syndrome (PCOS) symptoms include: acne, obesity, irregular or no periods, and excess hair growth. PCOS treatment depends on the woman's stage of life, which can include medication, birth control pills, and fertility treatments when pregnancy is desired.
- Metabolic SyndromeSource: MedicineNet
Metabolic syndrome risk factors include high blood pressure, obesity, high cholesterol, and insulin resistance. Prevention and treatment include lifestyle changes such as diet, exercise, and medication.
- Lipodystrophy (Acquired, Generalized, Inherited)Source: MedicineNet
Lipodystrophy is a syndrome in which body fat tissue is lost or abnormally accumulated in the whole body or just areas of it. Three forms of this disease are genetic (familial), acquired due to previous infections or HIV treatment), and congenital (present at birth). Diabetics often get it if they inject insulin in the same spot over a period of time.
- Glucose Tolerance TestSource: MedicineNet
Glucose tolerance test, was a routine oral glucose tolerance test ordered to diagnose type 2 diabetes, and gestational diabetes. Preparation, tests results interpretation, and testing during pregnancy are included.
- Panic AttacksSource: MedicineNet
Panic attacks may be a symptom of an anxiety disorder. Symptoms and signs of a panic attack include palpitations, shortness of breath, shaking, and chest pain. Treatment for panic attacks can include medications, avoiding triggers, getting adequate rest, and stress-reducing activities (yoga, exercise, etc.).
- Uterine CancerSource: Government
Learn uterine cancer symptoms, signs, prognosis, survival rate, stages, and treatment. Though the causes of endometrial cancer are unknown, there are various known risk factors. Learn about 5-year relative survival rates.
- Oral Diabetes Prescription MedicationsSource: RxList
What are oral diabetes medications and how do they work? Side effects, types and different among diabetes medications, warnings, and precautions are described. Some examples of oral medications used for diabetes are also included.
- Oral Diabetes Prescription MedicationsSource: WebMD Feature Archive
Information on types of prescription oral diabetes medications. Side effects, drug interactions, and patient information is included.
- Metformin Benefits Patients Historically Kept From Using itSource: WebMD Health News
Metformin treatment in patients with type 2 diabetes who have historical contraindications to the drug's use is associated with improved clinical outcomes, new research shows.
- FDA Lifts Final Regulatory Restrictions on RosiglitazoneSource: FDA
The US Food and Drug Administration (FDA) has removed the final remaining restrictions placed on the use of rosiglitazone.
- FDA: Metformin Safe for Some Patients With Renal ProblemsSource: WebMD Health News
In a response to mounting evidence, the US Food and Drug Administration (FDA) announced that the diabetes drug metformin can be used safely in patients with mild and, in some cases, moderate kidney impairment after decades of warning against it. This means that a generic and therefore cheap effective agent for type 2 diabetes should be more widely available for use, as many patients with diabetes also have some form of renal impairment.
- Common Diabetes Drug May Fight CancerSource: WebMD Health News
The diabetes drug metformin is sparking new interest as a cancer fighter.
- Metformin for Obesity in Children: Questions Still RemainSource: WebMD Health News
Among obese children without diabetes, metformin improves body mass index (BMI) and inflammatory and cardiovascular-related obesity parameters in prepubertal children but not in pubertal children, a new study shows.
- Diabetes Drug Metformin Linked to B12 DeficiencySource: WebMD Health News
Peripheral Neuropathy Patients Who Take Diabetes Drug May Have Vitamin B12 Deficiency
- Diabetes Drug Metformin May Fight CancerSource: WebMD Health News
In new research from the Mayo Clinic, ovarian cancer patients who took the drug metformin survived longer than patients who did not take it.
- EU Relaxes Metformin Indication to Include Moderate CKDSource: WebMD Health News
The European Medicines Agency (EMA) has announced that metformin-containing medicines can now be used in patients with moderately reduced kidney function — defined as a glomerular filtration rate (GFR) of 30 to 59 mL/min — for the treatment of type 2 diabetes.
- FDA OKs Linagliptin/Metformin Combo for Type 2 DiabetesSource: WebMD Health News
The US Food and Drug Administration (FDA) has approved a once-daily oral combination of linagliptin and metformin hydrochloride (Jentadueto XR, Boehringer Ingelheim and Eli Lilly & Co) for treating adults with type 2 diabetes.
- FDA OKs Metformin/Empagliflozin for Treatment-Naive DiabetesSource: WebMD Health News
- Metformin and Insulin Combo Cuts Mortality in Type 2 DiabetesSource: WebMD Health News
A new retrospective study indicates that, in type 2 diabetes, treatment with insulin is safer when it is used together with metformin.
- Metformin Gets Highest Marks in Diabetes StudySource: WebMD Health News
According to a new study, the drug metformin should be considered as a first choice for blood sugar control in people with type 2 diabetes.
- Metformin vs. Sulfonylureas for DiabetesSource: WebMD Health News
Concerns that the diabetes drugs Avandia and Actos raise the risk for heart failure led the FDA to require label changes warning of the potential risk two years ago.
- Metformin: Safer for Heart Than Older Diabetes Drugs?Source: WebMD Health News
In light of metformin, older people with type 2 diabetes who take an older class of oral diabetes drugs called sulfonylureas may have a higher risk of developing heart problems.
- NIH: Diabetes Drug Extends Health, Lifespan in MiceSource: FDA
Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led by researchers at the National Institute on Aging (NIA).
- FDA to Remove Certain Restrictions on AvandiaSource: FDA
The FDA today announced it is requiring the removal of certain restrictions on prescribing and use of the diabetes drug Avandia (rosiglitazone) to reflect new information regarding the cardiovascular risk of the medicine.
- Type 2 Diabetes in Kids a Challenge to ControlSource: WebMD Health News
Metformin plus Avandia is better than metformin alone for kids and teens with type 2 diabetes, according to a new government study.
- FDA Okays Synjardy, New Combo Medication for Type 2 DiabetesSource: WebMD Health News
The US Food and Drug Administration (FDA) has approved a new type 2 diabetes drug that combines the sodium glucose cotransporter 2 (SGLT2) inhibitor empagliflozin with metformin hydrochloride (Synjardy, Boehringer Ingelheim and Eli Lilly), according to a news release from the two companies.
- FDA Approves Three New Drug Treatments for Type 2 DiabetesSource: FDA
- New FDA Watch List Has Insulin Pens, Muscle Relaxants, and MoreSource: WebMD Health News
Updates to the US Food and Drug Administration's (FDA's) watch list include 27 drugs or drug classes for which there is new safety information or possible signs of serious risk.
- NIH Begins Recruitment for Long-term Study of Diabetes DrugSource: FDA
The National Institutes of Health is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
- Stopping Progression to DiabetesSource: WebMD Health News
In patients with prediabetes determined to be at high risk of progression to diabetes through oral glucose testing, treatment with a triple regimen of medications significantly reduced the likelihood of progression to type 2 diabetes compared with lifestyle modifications alone, according to new research.
- NIH Funds Studies to Improve Type 2 and Prediabetes TreatmentSource: FDA
The National Institutes of Health is looking for volunteers to take part in one of three clinical trials to improve and preserve the production of insulin in people with prediabetes or recently diagnosed type 2 diabetes. The project is called the Restoring Insulin Secretion study (RISE).
- New Diabetes Drug Drops Weight With Blood SugarSource: WebMD Health News
SGLT2 inhibitors, a new class of diabetes drugs, have an interesting side effect: weight loss.
- Manufacturers of Some Diabetes Drugs to Strengthen Warning on Heart Failure RiskSource: FDA
Read about FDA's increased heart failure risk warnings on Type 2 diabetes drugs on RxList.
- New Diabetes Drug Expected This WeekSource: WebMD Health News
A new oral diabetes drug is expected to arrive on pharmacy shelves in the U.S. this week.
- FDA Panel OKs Sanofi Insulin-GLP-1 Combo for DiabetesSource: WebMD Health News
A US Food and Drug Administration (FDA) advisory committee urged approval — though not without some reservations — of a new injectable knonwn generically as iGlarLixi that combines fixed doses of insulin glargine (Lantus, Sanofi) with lixisenatide (Lyxumia, Sanofi), a glucagon-like peptide 1 (GLP-1) receptor agonist still pending FDA approval for type 2 diabetes.
- IDegLira, LixiLan Go Head-to-head as FDA OKs Both for DiabetesSource: WebMD Health News
The US Food and Drug Administration (FDA) has approved two new competing combination products containing fixed doses of glucagonlike-peptide 1 (GLP-1) receptor agonists and long-acting insulins, from Sanofi and Novo Nordisk respectively, for the treatment of adults with type 2 diabetes.
- Exenatide-Pioglitazone Combo Tops Insulin in Type 2 DiabetesSource: WebMD Health News
A combination of pioglitazone and the glucagonlike peptide 1 (GLP-1) agonist exenatide (Bydureon, AstraZeneca) may represent an effective and safe alternative to insulin for the treatment of type 2 diabetes in patients who are poorly controlled despite use of both metformin and a sulfonylurea.
- FDA Approves Novel Combination Pill for Type 2 DiabetesSource: WebMD Health News
The US Food and Drug Administration has approved the empagliflozin/linagliptin combination Glyxambi (Boehringer Ingelheim/Eli Lilly) as adjunctive treatment to diet and exercise for adults with type 2 diabetes.
- Now Novo Says Semaglutide Cuts CV Risk: SUSTAIN-6 Top-line DataSource: WebMD Health News
Just over a month after Novo Nordisk announced positive top-line results for liraglutide (Victoza, Novo Nordisk), showing that it significantly reduced the risk of major adverse cardiovascular events in the LEADER Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results—A Long Term Evaluation (LEADER) trial, the company has announced another positive study of a similar agent — both are glucagonlike peptide-1 (GLP-1) agonists for the treatment of type 2 diabetes; this time it is a once-weekly product called semaglutide, which is not yet approved anywhere.
- Comparing Diabetes Drugs: Januvia vs. VictozaSource: WebMD Health News
Diabetic patients who took Victoza achieved better blood sugar control and lost more weight than patients who took the widely prescribed oral drug Januvia.
- FDA Warns of Heart Failure Risk With Two Diabetes DrugsSource: WebMD Health News
The US Food and Drug Administration (FDA) has issued a new alert about the potential for increased risk for heart failure in patients taking the type 2 diabetes drugs saxagliptin (Onglyza, AstraZeneca Pharmaceuticals LP) and alogliptin (Nesina, Takeda Pharmaceuticals).
- Top Prescriptions Index for 2010Source: RxList
- Top Prescriptions Index for 2011Source: RxList
- Intermittent Fasting Can Reverse Type 2 Diabetes in Some CasesSource: WebMD Health News
Therapeutic intermittent fasting may help eliminate the need for insulin and other glucose-lowering medications in patients with type 2 diabetes, a new case series suggests.
- First-Ever Guidelines for Children With DiabetesSource: WebMD Health News
Type 2 diabetes is rising rapidly among children and teens because of soaring obesity rates.
- Inhaled Insulin May Help Treat DiabetesSource: WebMD Health News
According to a new study, inhaled insulin proved to be as effective at lowering blood sugar levels as insulin injections, and with minimal side effects, among patients with uncontrolled type 2 diabetes.
- Oral Basal Insulin Shows Promise in Type 2 DiabetesSource: WebMD Health News
An oral basal insulin formulation has produced glycemic control equivalent to that of injected insulin glargine in insulin-naïve type 2 diabetes patients.
- FDA Reviewing Preliminary Safe Information On ActosSource: FDA
The diabetes drug Actos (pioglitazone) is under FDA review due to its association with bladder cancer.
- New Insight Into Insulin Dose and Mortality in Type 2 DiabetesSource: WebMD Health News
Higher insulin doses do not raise the risks for mortality or major adverse cardiovascular events (MACE) in patients with type 2 diabetes, new research indicates, after careful adjustment for potential confounders.
- Top Prescriptions Index for 2009Source: RxList